Your session is about to expire
← Back to Search
Amygdala recording and stimulation using Neuropace RNS for Panic Disorder
Study Summary
This trial will test the feasibility of a new procedure to study the human amygdala, as well as the effects of stimulation on fear and reward processing.
- Panic Disorder
- Post-Traumatic Stress Disorder
- Anxiety
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment for this experiment currently underway?
"The clinicaltrial.gov website informs that this medical trial is no longer accepting candidates, having posted initially on April 24th 2019 and last modified September 20th 2021. Nevertheless, 359 other studies are actively seeking patients at present."
Are individuals 55 years and older being enrolled in this experimental program?
"Candidates wishing to take part in this trial must fall within the 18-65 age bracket. For those younger than 18, there are 48 studies available and 261 for individuals over 65 years of age."
Can I be part of this experiment?
"To be eligible for inclusion in this trial, participants must suffer from panic attacks and have an age between 18 to 65. There are 30 open slots available overall."
Share this study with friends
Copy Link
Messenger